293 related articles for article (PubMed ID: 22574771)
1. The biology and mechanism of action of suppressor of cytokine signaling 3.
Babon JJ; Nicola NA
Growth Factors; 2012 Aug; 30(4):207-19. PubMed ID: 22574771
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of IL-6 family cytokines by SOCS3.
Babon JJ; Varghese LN; Nicola NA
Semin Immunol; 2014 Feb; 26(1):13-9. PubMed ID: 24418198
[TBL] [Abstract][Full Text] [Related]
3. Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity.
Babon JJ; Kershaw NJ; Murphy JM; Varghese LN; Laktyushin A; Young SN; Lucet IS; Norton RS; Nicola NA
Immunity; 2012 Feb; 36(2):239-50. PubMed ID: 22342841
[TBL] [Abstract][Full Text] [Related]
4. The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo.
Boyle K; Egan P; Rakar S; Willson TA; Wicks IP; Metcalf D; Hilton DJ; Nicola NA; Alexander WS; Roberts AW; Robb L
Blood; 2007 Sep; 110(5):1466-74. PubMed ID: 17510322
[TBL] [Abstract][Full Text] [Related]
5. Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation.
Boyle K; Zhang JG; Nicholson SE; Trounson E; Babon JJ; McManus EJ; Nicola NA; Robb L
Cell Signal; 2009 Mar; 21(3):394-404. PubMed ID: 19056487
[TBL] [Abstract][Full Text] [Related]
6. SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition.
Kershaw NJ; Murphy JM; Liau NP; Varghese LN; Laktyushin A; Whitlock EL; Lucet IS; Nicola NA; Babon JJ
Nat Struct Mol Biol; 2013 Apr; 20(4):469-76. PubMed ID: 23454976
[TBL] [Abstract][Full Text] [Related]
7. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Mol Endocrinol; 2007 Oct; 21(10):2503-15. PubMed ID: 17609438
[TBL] [Abstract][Full Text] [Related]
8. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130.
Lehmann U; Schmitz J; Weissenbach M; Sobota RM; Hortner M; Friederichs K; Behrmann I; Tsiaris W; Sasaki A; Schneider-Mergener J; Yoshimura A; Neel BG; Heinrich PC; Schaper F
J Biol Chem; 2003 Jan; 278(1):661-71. PubMed ID: 12403768
[TBL] [Abstract][Full Text] [Related]
9. Socs3 maintains the specificity of biological responses to cytokine signals during granulocyte and macrophage differentiation.
Croker BA; Mielke LA; Wormald S; Metcalf D; Kiu H; Alexander WS; Hilton DJ; Roberts AW
Exp Hematol; 2008 Jul; 36(7):786-98. PubMed ID: 18400361
[TBL] [Abstract][Full Text] [Related]
10. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M receptor-mediated signal transduction is negatively regulated by SOCS3 through a receptor tyrosine-independent mechanism.
Stross C; Radtke S; Clahsen T; Gerlach C; Volkmer-Engert R; Schaper F; Heinrich PC; Hermanns HM
J Biol Chem; 2006 Mar; 281(13):8458-68. PubMed ID: 16459330
[TBL] [Abstract][Full Text] [Related]
12. Extended anti-inflammatory action of a degradation-resistant mutant of cell-penetrating suppressor of cytokine signaling 3.
Fletcher TC; DiGiandomenico A; Hawiger J
J Biol Chem; 2010 Jun; 285(24):18727-36. PubMed ID: 20400504
[TBL] [Abstract][Full Text] [Related]
13. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
van de Geijn GJ; Gits J; Touw IP
J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
[TBL] [Abstract][Full Text] [Related]
14. CUEDC2 (CUE domain-containing 2) and SOCS3 (suppressors of cytokine signaling 3) cooperate to negatively regulate Janus kinase 1/signal transducers and activators of transcription 3 signaling.
Zhang WN; Wang L; Wang Q; Luo X; Fang DF; Chen Y; Pan X; Man JH; Xia Q; Jin BF; Li WH; Li T; Liang B; Chen L; Gong WL; Yu M; Li AL; Zhou T; Li HY
J Biol Chem; 2012 Jan; 287(1):382-392. PubMed ID: 22084247
[TBL] [Abstract][Full Text] [Related]
15. Structure and function of a new STAT-induced STAT inhibitor.
Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
[TBL] [Abstract][Full Text] [Related]
16. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of SOCS3 phosphorylation upon interleukin-6 stimulation. Contributions of Src- and receptor-tyrosine kinases.
Sommer U; Schmid C; Sobota RM; Lehmann U; Stevenson NJ; Johnston JA; Schaper F; Heinrich PC; Haan S
J Biol Chem; 2005 Sep; 280(36):31478-88. PubMed ID: 16000307
[TBL] [Abstract][Full Text] [Related]
18. Reconstruction of an active SOCS3-based E3 ubiquitin ligase complex in vitro: identification of the active components and JAK2 and gp130 as substrates.
Kershaw NJ; Laktyushin A; Nicola NA; Babon JJ
Growth Factors; 2014 Feb; 32(1):1-10. PubMed ID: 24438103
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
[TBL] [Abstract][Full Text] [Related]
20. Key role of suppressor of cytokine signaling 3 in regulating gp130 cytokine-induced signaling and limiting chondrocyte responses during murine inflammatory arthritis.
Liu X; Croker BA; Campbell IK; Gauci SJ; Alexander WS; Tonkin BA; Walsh NC; Linossi EM; Nicholson SE; Lawlor KE; Wicks IP
Arthritis Rheumatol; 2014 Sep; 66(9):2391-402. PubMed ID: 24839265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
